Vico Therapeutics


The icon of our Vico logo symbolizes an oligonucleotide in the shape of a brain, representing the technology we use to develop therapies for diseases of the central nervous system.

Vico was founded in Q4 2019 by the highly experienced entrepreneurs Luc Dochez and Josh Mandel-Brehm and seasoned scientists  Dr. Judith van Deutekom and Dr. Gail Mandel with strong academic reputations and vast industry experience.

Together with a team of skilled scientists and drug development professionals, Vico’s focus is on development of RNA modulating therapies for rare neurological disorders, with initial focus on SCA – Spinocerebellar ataxiaHD – Huntington’s disease and RETT syndrome.